126 results
Page 3 of 7
8-K
EX-99.1
hsd414zx 3hzw3m378le
7 May 20
Results of Operations and Financial Condition
7:00am
PRE 14A
ar6j 4985f64
19 Mar 20
Preliminary proxy
4:19pm
8-K
EX-99.1
spzvgb3to
12 Feb 20
Results of Operations and Financial Condition
7:07am
8-K
EX-10.1
e4k3kt
10 Apr 19
Entry into a Material Definitive Agreement
8:01am
10-K
2o5 61dzlxw5lno
12 Feb 18
Annual report
12:00am
424B5
voam9cik0si4m
18 Jul 16
Prospectus supplement for primary offering
12:00am
6-K
82vbu0xra2ho5iuf8
30 Nov 15
Current report (foreign)
12:00am
424B5
fpsuo10is0 cg3
30 Nov 15
Prospectus supplement for primary offering
12:00am
424B5
xkh3o
30 Nov 15
Prospectus supplement for primary offering
12:00am
6-K
EX-99.2
rh8tof7 faftxvpr
27 Jul 15
Teva to Acquire Allergan Generics for $40.5 Billion
12:00am
6-K
EX-99.1
7p6obbc7gike8
27 Jul 15
Teva to Acquire Allergan Generics for $40.5 Billion
12:00am
425
ola9lq4qg7
8 Jun 15
Business combination disclosure
12:00am
425
h61yb908f4jjmryp5v
21 Apr 15
Business combination disclosure
12:00am
6-K
EX-99.1
ve820czvnkqaauxg2
21 Apr 15
Teva Proposes to Acquire Mylan for $82.00 Per Share In Cash and Stock
12:00am
425
bo9hol aza6qwv06
21 Apr 15
Business combination disclosure
12:00am
425
qx1ki5
21 Apr 15
Business combination disclosure
12:00am